CClinicalTrials.gg
CompletedNCT02396290Updated Mar 24, 2015

Clinical Effect of Platelet Rich Plasma Combined With Laser on Scar

An interventional study of fractional carbon dioxide laser with platelet rich plasma and fractional carbon dioxide laser with NS in Acne Scar, sponsored by Seoul National University Hospital. Completed at 1 site in Korea, Republic of. Open to participants aged 19 Years to 40 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2015-03-24.

Sponsored by Seoul National University Hospital · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
29
Allocation
Randomized
Ages
19 Years to 40 Years
Sex
All
01

Study summary

Investigation of Clinical Effect of Platelet Rich Plasma Combined With Laser on Acne Scar

Read the detailed description

Platelet Rich Plasma may relieve the adverse effect of laser treatment. and it can be expected to improve acne treatment result.

02

Conditions studied

  • Acne Scar

Browse trials for

Keywords

  • acne scar
  • fractional carbon dioxide laser
  • platelet rich plasma
03

In context

Cicatrix

307 studies on the registry are indexed under Cicatrix; 50 are open to participants now.

This study's enrollment of 29 is below the median of 39 across 251 interventional studies indexed under Cicatrix.

Browse Cicatrix studies →

Lead sponsor

Seoul National University Hospital is the lead sponsor of 1,860 studies on the registry; 275 are open to participants now.

Of its 12 completed or terminated interventional studies of FDA-regulated products, 2 (17%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
19 Years to 40 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • moderate to severe acne scar

Exclusion criteria

Exclusion Criteria:

  • taken procedures for acne scar within 6 months
  • underlying diabetes mellitus, keloid, or malignancy
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Single group
Masking
Double (Participant, Outcomes assessor)
Enrollment
29 participants (actual)

Study arms

  • Experimental
    fractional CO2 laser with PRP

    fractional carbon dioxide laser followed by intradermal injection of platelet rich plasma

    Procedure: fractional carbon dioxide laser with platelet rich plasma

  • Active comparator
    fractional CO2 laser with NS

    fractional carbon dioxide laser followed by intradermal injection of NS

    Procedure: fractional carbon dioxide laser with NS

Interventions

  • Procedurefractional carbon dioxide laser with platelet rich plasma

    fractional carbon dioxide laser followed by platelet rich plasma injection

    Also known as: COFRAX with autologous PRP

  • Procedurefractional carbon dioxide laser with NS

    fractional carbon dioxide laser followed by normal saline injection

    Also known as: COFRAX with normal saline

06

What researchers measure

Primary outcomes

  1. Global assessment of acne scar

    5-point grading of acne scar

    Time frame: 12 weeks

Secondary outcomes

  1. ECCA (échelle d'évaluation clinique des cicatrices d'acné)

    quantitative analysis of acne scar

    Time frame: 12 weeks

  2. adverse effect assessment

    adverse effect assessment - erythema index, Epithelization Scale (0-12 point)

    Time frame: 12 weeks

07

Study locations

1 site
  • Department of Dermatology, Seoul National University College of Medicine
    Seoul, 110-744, Korea, Republic of
08

References and documents

Publications

  • Tierney EP, Eisen RF, Hanke CW. Fractionated CO2 laser skin rejuvenation. Dermatol Ther. 2011 Jan-Feb;24(1):41-53. doi: 10.1111/j.1529-8019.2010.01377.x. PubMed 21276157 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 24, 2015, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02396290
Lead sponsor
Seoul National University Hospital
Responsible party
Sponsor
First posted
Mar 24, 2015
Start date
Mar 2013
Primary completion
Sep 2013
Completion
Sep 2013
Last update
Mar 24, 2015

Study contacts

Dae Hun Suh, PhD
study chair · Department of Dermatology, Seoul National University College of Medicine
Seonguk Min, Msc
principal investigator · Department of Dermatology, Seoul National University College of Medicine

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2013. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion